{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:41:59Z","timestamp":1794573719121,"version":"4.9.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T00:00:00Z","timestamp":1606262400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T00:00:00Z","timestamp":1606262400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT107881"],"award-info":[{"award-number":["WT107881"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT110303"],"award-info":[{"award-number":["WT110303"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["083650"],"award-info":[{"award-number":["083650"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"crossref","award":["WT105920"],"award-info":[{"award-number":["WT105920"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_00002\/4"],"award-info":[{"award-number":["MC_UU_00002\/4"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_00002\/13"],"award-info":[{"award-number":["MC_UU_00002\/13"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Genome-wide association studies (GWAS) have identified pervasive sharing of genetic architectures across multiple immune-mediated diseases (IMD). By learning the genetic basis of IMD risk from common diseases, this sharing can be exploited to enable analysis of less frequent IMD where, due to limited sample size, traditional GWAS techniques are challenging.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Exploiting ideas from Bayesian genetic fine-mapping, we developed a disease-focused shrinkage approach to allow us to distill genetic risk components from GWAS summary statistics for a set of related diseases. We applied this technique to 13 larger GWAS of common IMD, deriving a reduced dimension \u201cbasis\u201d that summarised the multidimensional components of genetic risk. We used independent datasets including the UK Biobank to assess the performance of the basis and characterise individual axes. Finally, we projected summary GWAS data for smaller IMD studies, with less than 1000 cases, to assess whether the approach was able to provide additional insights into genetic architecture of less common IMD or IMD subtypes, where cohort collection is challenging.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We identified 13 IMD genetic risk components. The projection of independent UK Biobank data demonstrated the IMD specificity and accuracy of the basis even for traits with very limited case-size (e.g. vitiligo, 150 cases). Projection of additional IMD-relevant studies allowed us to add biological interpretation to specific components, e.g. related to raised eosinophil counts in blood and serum concentration of the chemokine CXCL10 (IP-10). On application to 22 rare IMD and IMD subtypes, we were able to not only highlight subtype-discriminating axes (e.g. for juvenile idiopathic arthritis) but also suggest eight novel genetic associations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Requiring only summary-level data, our unsupervised approach allows the genetic architectures across any range of clinically related traits to be characterised in fewer dimensions. This facilitates the analysis of studies with modest sample size by matching shared axes of both genetic and biological risk across a wider disease domain, and provides an evidence base for possible therapeutic repurposing opportunities.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13073-020-00797-4","type":"journal-article","created":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T11:02:48Z","timestamp":1606302168000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Genetic feature engineering enables characterisation of shared risk factors in immune-mediated diseases"],"prefix":"10.1186","volume":"12","author":[{"given":"Oliver S.","family":"Burren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Reales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limy","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Bowes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth G. C.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D. W.","family":"Kirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9755-1703","authenticated-orcid":false,"given":"Chris","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,25]]},"reference":[{"key":"797_CR1","doi-asserted-by":"publisher","first-page":"D1005","DOI":"10.1093\/nar\/gky1120","volume":"47","author":"A Buniello","year":"2019","unstructured":"Buniello A, et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 2019;47:D1005\u201312.","journal-title":"Nucleic Acids Res"},{"key":"797_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.it.2012.09.001","volume":"34","author":"C Cotsapas","year":"2013","unstructured":"Cotsapas C, Hafler DA. Immune-mediated disease genetics: the shared basis of pathogenesis. Trends Immunol. 2013;34:22\u20136.","journal-title":"Trends Immunol"},{"key":"797_CR3","doi-asserted-by":"publisher","unstructured":"Bovijn, J., Censin, J. C., Lindgren, C. M. & Holmes, M. V. Using human genetics to guide the repurposing of medicines. Int J Epidemiol. 2020; https:\/\/doi.org\/10.1093\/ije\/dyaa015.","DOI":"10.1093\/ije\/dyaa015"},{"key":"797_CR4","doi-asserted-by":"crossref","unstructured":"Majumdar A, Haldar T, Bhattacharya S, Witte JS. An efficient Bayesian meta-analysis approach for studying cross-phenotype genetic associations. PLoS Genet. 2018;14:e1007139.","DOI":"10.1371\/journal.pgen.1007139"},{"key":"797_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002254","volume":"7","author":"C Cotsapas","year":"2011","unstructured":"Cotsapas C, et al. Pervasive sharing of genetic effects in autoimmune disease. PLoS Genet. 2011;7:e1002254.","journal-title":"PLoS Genet"},{"key":"797_CR6","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/ng.3406","volume":"47","author":"B Bulik-Sullivan","year":"2015","unstructured":"Bulik-Sullivan B, et al. An atlas of genetic correlations across human diseases and traits. Nat Genet. 2015;47:1236\u201341.","journal-title":"Nat Genet"},{"key":"797_CR7","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/ng.3330","volume":"47","author":"MD Fortune","year":"2015","unstructured":"Fortune MD, et al. Statistical colocalization of genetic risk variants for related autoimmune diseases in the context of common controls. Nat. Genet. 2015;47:839.","journal-title":"Nat. Genet."},{"key":"797_CR8","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1056\/NEJMoa1306555","volume":"369","author":"Y Yang","year":"2013","unstructured":"Yang Y, et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl J Med. 2013;369:1502\u201311.","journal-title":"N Engl J Med"},{"key":"797_CR9","doi-asserted-by":"publisher","unstructured":"Ouwehand WH. Whole-genome sequencing of rare disease patients in a national healthcare system. Nature. https:\/\/doi.org\/10.1101\/507244.","DOI":"10.1101\/507244"},{"key":"797_CR10","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1038\/s41467-018-04332-3","volume":"9","author":"K Estrada","year":"2018","unstructured":"Estrada K, et al. A whole-genome sequence study identifies genetic risk factors for neuromyelitis optica. Nat Commun. 2018;9:1929.","journal-title":"Nat Commun"},{"key":"797_CR11","doi-asserted-by":"publisher","first-page":"6804","DOI":"10.1038\/ncomms7804","volume":"6","author":"J Li","year":"2015","unstructured":"Li J, et al. Association of CLEC16A with human common variable immunodeficiency disorder and role in murine B cells. Nat Commun. 2015;6:6804.","journal-title":"Nat Commun"},{"key":"797_CR12","doi-asserted-by":"publisher","first-page":"5120","DOI":"10.1038\/s41467-019-12515-9","volume":"10","author":"PA Lyons","year":"2019","unstructured":"Lyons PA, et al. Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status. Nat Commun. 2019;10:5120.","journal-title":"Nat Commun"},{"key":"797_CR13","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/ng1847","volume":"38","author":"AL Price","year":"2006","unstructured":"Price AL, et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006;38:904\u20139.","journal-title":"Nat Genet"},{"key":"797_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1003820","volume":"10","author":"D Chang","year":"2014","unstructured":"Chang D, Keinan A. Principal component analysis characterizes shared pathogenetics from genome-wide association studies. PLoS Comput Biol. 2014;10:e1003820.","journal-title":"PLoS Comput Biol"},{"key":"797_CR15","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.1038\/s41467-019-11953-9","volume":"10","author":"Y Tanigawa","year":"2019","unstructured":"Tanigawa Y, et al. Components of genetic associations across 2,138 phenotypes in the UK Biobank highlight adipocyte biology. Nat Commun. 2019;10:4064.","journal-title":"Nat Commun"},{"key":"797_CR16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/gepi.20359","volume":"33","author":"J Wakefield","year":"2009","unstructured":"Wakefield J. Bayes factors for genome-wide association studies: comparison with P -values. Genet. Epidemiol. 2009;33:79\u201386.","journal-title":"Genet. Epidemiol"},{"key":"797_CR17","doi-asserted-by":"crossref","unstructured":"The Wellcome Trust Case Control Consortium et al. Bayesian refinement of association signals for 14 loci in 3 common diseases. Nat. Genet.2012 44, 1294-1301.","DOI":"10.1038\/ng.2435"},{"key":"797_CR18","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.cell.2016.10.042","volume":"167","author":"WJ Astle","year":"2016","unstructured":"Astle WJ, et al. The allelic landscape of human blood cell trait variation and links to common complex disease. Cell. 2016;167:1415\u201329.e19.","journal-title":"Cell"},{"key":"797_CR19","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cell.2015.02.046","volume":"161","author":"M Roederer","year":"2015","unstructured":"Roederer M, et al. The genetic architecture of the human immune system: a bioresource for autoimmunity and disease pathogenesis. Cell. 2015;161:387\u2013403.","journal-title":"Cell"},{"key":"797_CR20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ajhg.2016.11.007","volume":"100","author":"AV Ahola-Olli","year":"2017","unstructured":"Ahola-Olli AV, et al. Genome-wide association study identifies 27 loci influencing concentrations of circulating cytokines and growth factors. Am J Hum Genet. 2017;100:40\u201350.","journal-title":"Am J Hum Genet"},{"key":"797_CR21","doi-asserted-by":"crossref","unstructured":"Aterido A, et al. Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis. Ann Rheum Dis. 2019;78:355\u201364.","DOI":"10.1136\/annrheumdis-2018-214158"},{"key":"797_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007371","volume":"14","author":"S R\u00fceger","year":"2018","unstructured":"R\u00fceger S, McDaid A, Kutalik Z. Evaluation and application of summary statistic imputation to discover new height-associated loci. PLoS Genet. 2018;14:e1007371.","journal-title":"PLoS Genet"},{"key":"797_CR23","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1038\/nn.4040","volume":"18","author":"RA Power","year":"2015","unstructured":"Power RA, et al. Polygenic risk scores for schizophrenia and bipolar disorder predict creativity. Nat Neurosci. 2015;18:953\u20135.","journal-title":"Nat Neurosci"},{"key":"797_CR24","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/j.1467-9574.2006.00343.x","volume":"60","author":"D Yekutieli","year":"2006","unstructured":"Yekutieli D, et al. Approaches to multiplicity issues in complex research in microarray analysis. Stat Neerl. 2006;60:414\u201337.","journal-title":"Stat Neerl"},{"key":"797_CR25","first-page":"664","volume":"45","author":"A Hinks","year":"2013","unstructured":"Hinks A, et al. Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis. Nat Publ Group. 2013;45:664\u20139.","journal-title":"Nat Publ Group"},{"key":"797_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12:e1001779.","journal-title":"PLoS Med"},{"key":"797_CR27","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0031-3203(80)90042-4","volume":"12","author":"SP Smith","year":"1980","unstructured":"Smith SP, Dubes R. Stability of a hierarchical clustering. Pattern Recogn. 1980;12:177\u201387.","journal-title":"Pattern Recogn"},{"key":"797_CR28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cell.2019.02.048","volume":"177","author":"G Sirugo","year":"2019","unstructured":"Sirugo G, Williams SM, Tishkoff SA. The missing diversity in human genetic studies. Cell. 2019;177:26\u201331.","journal-title":"Cell"},{"key":"797_CR29","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1001\/jamaneurol.2014.4103","volume":"72","author":"AE Renton","year":"2015","unstructured":"Renton AE, et al. A genome-wide association study of myasthenia gravis. JAMA Neurol. 2015;72:396\u2013404.","journal-title":"JAMA Neurol"},{"key":"797_CR30","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jbspin.2013.09.003","volume":"81","author":"S Thierry","year":"2014","unstructured":"Thierry S, Fautrel B, Lemelle I, Guillemin F. Prevalence and incidence of juvenile idiopathic arthritis: a systematic review. Joint Bone Spine. 2014;81:112\u20137.","journal-title":"Joint Bone Spine"},{"key":"797_CR31","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390\u20132.","journal-title":"J Rheumatol"},{"key":"797_CR32","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1136\/annrheumdis-2016-210324","volume":"76","author":"MJ Ombrello","year":"2017","unstructured":"Ombrello MJ, et al. Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications. Ann Rheum Dis. 2017;76:906\u201313.","journal-title":"Ann Rheum Dis"},{"key":"797_CR33","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1136\/annrheumdis-2016-210025","volume":"76","author":"A Hinks","year":"2017","unstructured":"Hinks A, et al. Fine-mapping the MHC locus in juvenile idiopathic arthritis (JIA) reveals genetic heterogeneity corresponding to distinct adult inflammatory arthritic diseases. Ann Rheum Dis. 2017;76:765\u201372.","journal-title":"Ann Rheum Dis"},{"key":"797_CR34","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/ana.23691","volume":"72","author":"PK Gregersen","year":"2012","unstructured":"Gregersen PK, et al. Risk for myasthenia gravis maps to a (151) Pro\u2192Ala change in TNIP1 and to human leukocyte antigen-B*08. Ann Neurol. 2012;72:927\u201335.","journal-title":"Ann Neurol"},{"key":"797_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030297","volume":"3","author":"D McGonagle","year":"2006","unstructured":"McGonagle D, McDermott MF. A proposed classification of the immunological diseases. PLoS Med. 2006;3:e297.","journal-title":"PLoS Med"},{"key":"797_CR36","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s12016-017-8622-7","volume":"54","author":"K Boniface","year":"2018","unstructured":"Boniface K, Seneschal J, Picardo M, Ta\u00efeb A. Vitiligo: focus on clinical aspects, immunopathogenesis, and therapy. Clin Rev Allergy Immunol. 2018;54:52\u201367.","journal-title":"Clin Rev Allergy Immunol"},{"key":"797_CR37","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1002\/art.40830","volume":"71","author":"Y Yuan","year":"2019","unstructured":"Yuan Y, et al. Identification of novel autoantibodies associated with psoriatic arthritis. Arthritis Rheumatol. 2019;71:941\u201351.","journal-title":"Arthritis Rheumatol"},{"key":"797_CR38","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1053\/j.gastro.2011.07.039","volume":"141","author":"H Singh","year":"2011","unstructured":"Singh H, Nugent Z, Demers AA, Bernstein CN. Increased risk of nonmelanoma skin cancers among individuals with inflammatory bowel disease. Gastroenterology. 2011;141:1612\u201320.","journal-title":"Gastroenterology"},{"key":"797_CR39","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.cgh.2013.04.033","volume":"12","author":"S Singh","year":"2014","unstructured":"Singh S, et al. Inflammatory bowel disease is associated with an increased risk of melanoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2014;12:210\u20138.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"797_CR40","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s12026-016-8841-7","volume":"65","author":"B-H Toh","year":"2017","unstructured":"Toh B-H. Pathophysiology and laboratory diagnosis of pernicious anemia. Immunol Res. 2017;65:326\u201330.","journal-title":"Immunol Res"},{"key":"797_CR41","first-page":"286","volume":"68","author":"WW Busse","year":"1992","unstructured":"Busse WW, Sedgwick JB. Eosinophils in asthma. Ann Allergy. 1992;68:286\u201390.","journal-title":"Ann Allergy"},{"key":"797_CR42","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1136\/gut.2005.072595","volume":"54","author":"S Al-Haddad","year":"2005","unstructured":"Al-Haddad S, Riddell RH. The role of eosinophils in inflammatory bowel disease. Gut. 2005;54:1674\u20135.","journal-title":"Gut"},{"key":"797_CR43","first-page":"539","volume":"59","author":"R H\u00e4llgren","year":"1985","unstructured":"H\u00e4llgren R, Feltelius N, Svenson K, Venge P. Eosinophil involvement in rheumatoid arthritis as reflected by elevated serum levels of eosinophil cationic protein. Clin Exp Immunol. 1985;59:539\u201346.","journal-title":"Clin Exp Immunol"},{"key":"797_CR44","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3389\/fimmu.2017.00484","volume":"8","author":"NL Diny","year":"2017","unstructured":"Diny NL, Rose NR, \u010cih\u00e1kov\u00e1 D. Eosinophils in autoimmune diseases. Front Immunol. 2017;8:484.","journal-title":"Front Immunol"},{"key":"797_CR45","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.4049\/jimmunol.171.12.6838","volume":"171","author":"U Christen","year":"2003","unstructured":"Christen U, McGavern DB, Luster AD, von Herrath MG, Oldstone MBA. Among CXCR3 chemokines, IFN-gamma-inducible protein of 10 kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-gamma (CXCL9) imprints a pattern for the subsequent development of autoimmune disease. J Immunol. 2003;171:6838\u201345.","journal-title":"J Immunol"},{"key":"797_CR46","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0002-9440(10)64171-5","volume":"161","author":"P Romagnani","year":"2002","unstructured":"Romagnani P, et al. Expression of IP-10\/CXCL10 and MIG\/CXCL9 in the thyroid and increased levels of IP-10\/CXCL10 in the serum of patients with recent-onset Graves\u2019 disease. Am J Pathol. 2002;161:195\u2013206.","journal-title":"Am J Pathol"},{"key":"797_CR47","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1182\/blood-2005-06-2383","volume":"108","author":"A Meraouna","year":"2006","unstructured":"Meraouna A, et al. The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis. Blood. 2006;108:432\u201340.","journal-title":"Blood"},{"key":"797_CR48","doi-asserted-by":"publisher","first-page":"510","DOI":"10.2337\/diacare.24.3.510","volume":"24","author":"A Shimada","year":"2001","unstructured":"Shimada A, et al. Elevated serum IP-10 levels observed in type 1 diabetes. Diabetes Care. 2001;24:510\u20135.","journal-title":"Diabetes Care"},{"key":"797_CR49","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/j.1464-5491.2008.02577.x","volume":"25","author":"A Antonelli","year":"2008","unstructured":"Antonelli A, et al. Serum Th1 (CXCL10) and Th2 (CCL2) chemokine levels in children with newly diagnosed type 1 diabetes: a longitudinal study. Diabet Med. 2008;25:1349\u201353.","journal-title":"Diabet Med"},{"key":"797_CR50","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1365-2249.2009.03880.x","volume":"156","author":"KO Kong","year":"2009","unstructured":"Kong KO, et al. Enhanced expression of interferon-inducible protein-10 correlates with disease activity and clinical manifestations in systemic lupus erythematosus. Clin Exp Immunol. 2009;156:134\u201340.","journal-title":"Clin Exp Immunol"},{"key":"797_CR51","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cyto.2016.01.012","volume":"81","author":"J Wang","year":"2016","unstructured":"Wang J, et al. Circulating levels of Th1 and Th2 chemokines in patients with ankylosing spondylitis. Cytokine. 2016;81:10\u20134.","journal-title":"Cytokine"},{"key":"797_CR52","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft C, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562:203\u20139.","journal-title":"Nature"},{"key":"797_CR53","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41467-017-00257-5","volume":"8","author":"C Tian","year":"2017","unstructured":"Tian C, et al. Genome-wide association and HLA region fine-mapping studies identify susceptibility loci for multiple common infections. Nat Commun. 2017;8:599.","journal-title":"Nat Commun"},{"key":"797_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002322","volume":"7","author":"CL Avery","year":"2011","unstructured":"Avery CL, et al. A phenomics-based strategy identifies loci on APOC1, BRAP, and PLCG1 associated with metabolic syndrome phenotype domains. PLoS Genet. 2011;7:e1002322.","journal-title":"PLoS Genet"},{"key":"797_CR55","doi-asserted-by":"publisher","unstructured":"Mallard, T. T. et al. Not just one p: multivariate GWAS of psychiatric disorders and their cardinal symptoms reveal two dimensions of cross-cutting genetic liabilities. bioRxiv 603134 (2019) https:\/\/doi.org\/10.1101\/603134.","DOI":"10.1101\/603134"},{"key":"797_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002654","volume":"15","author":"MS Udler","year":"2018","unstructured":"Udler MS, et al. Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: a soft clustering analysis. PLoS Med. 2018;15:e1002654.","journal-title":"PLoS Med"},{"key":"797_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004383","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei C, et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 2014;10:e1004383.","journal-title":"PLoS Genet"},{"key":"797_CR58","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1002\/art.34330","volume":"64","author":"M Yellin","year":"2012","unstructured":"Yellin M, et al. A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis. Arthritis Rheum. 2012;64:1730\u20139.","journal-title":"Arthritis Rheum"},{"key":"797_CR59","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1136\/gutjnl-2012-303424","volume":"63","author":"L Mayer","year":"2014","unstructured":"Mayer L, et al. Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised study. Gut. 2014;63:442\u201350.","journal-title":"Gut"},{"issue":"4","key":"797_CR60","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/s41397-018-0025-5","volume":"18","author":"JC Taylor","year":"2018","unstructured":"Taylor JC, et al. Genome-wide association study of response to methotrexate in early rheumatoid arthritis patients. Pharmacogenetics J. 2018;18(4):528\u201338.","journal-title":"Pharmacogenetics J"},{"issue":"22","key":"797_CR61","doi-asserted-by":"publisher","first-page":"6081","DOI":"10.1093\/hmg\/ddu307","volume":"23","author":"JJW Kuiper","year":"2014","unstructured":"Kuiper JJW, et al. A genome-wide association study identifies a functional ERAP2 haplotype associated with birdshot chorioretinopathy. Hum Mol Genet. 2014;23(22):6081\u20137.","journal-title":"Hum Mol Genet"},{"key":"797_CR62","unstructured":"Burren, O.S., Wallace, C. cupcake. Github. https:\/\/github.com\/ollyburren\/cupcake\/ (2020)."},{"key":"797_CR63","doi-asserted-by":"crossref","unstructured":"Burren, O. S., Wallace, C. R code to support \u201cGenetic feature engineering enables characterisation of shared risk factors in immune-mediated diseases\u201d. Zenodo. https:\/\/zenodo.org\/record\/4069214 (2020).","DOI":"10.1186\/s13073-020-00797-4"},{"key":"797_CR64","unstructured":"Reales, G., Burren, O.S. IMD basis App. shinyapps.io. https:\/\/grealesm.shinyapps.io\/IMDbasisApp\/ (2020)."},{"key":"797_CR65","unstructured":"Reales, G., Burren, O.S. IMD basis App. Github. https:\/\/github.com\/GRealesM\/IMDbasisApp (2020)."}],"container-title":["Genome Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-020-00797-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13073-020-00797-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-020-00797-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T20:50:55Z","timestamp":1697230255000},"score":1,"resource":{"primary":{"URL":"https:\/\/genomemedicine.biomedcentral.com\/articles\/10.1186\/s13073-020-00797-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,25]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["797"],"URL":"https:\/\/doi.org\/10.1186\/s13073-020-00797-4","relation":{},"ISSN":["1756-994X"],"issn-type":[{"value":"1756-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,25]]},"assertion":[{"value":"18 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All PsA patients provided written informed consent (UK PsA National Repository MREC 99\/8\/84). Ethical approval was given by the HRA and North West-Haydock Research Ethics Committee.JIA participants were recruited with ethical approval and provided informed consent, from the North West Multi-centre for Research Ethics Committee (MREC:02\/8\/104 and MREC:99\/8\/84), West Midlands Multi-centre Research Ethics Committee (MREC:02\/7\/106), North West Research Ethics Committee (REC:09\/H1008\/137), and NHS Research Ethics Committee (REC:05\/Q0508\/95).The research conformed to the principles of the Helsinki Declaration.All other datasets were publicly available, and ethical approval was not required for our use of them.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"106"}}